Clinical Trial

Pathogenic Study of Adult Immune Enteropathies

Study acronym: ENTEROPATH
Recruiting
View on ClinicalTrials.gov →
Summary
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-20; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2020-07-28
Trial Details
NCT Number NCT04280510
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Collaborators: Imagine Institute
Conditions Celiac Disease, Autoimmune Enteropathy, Inflammatory Bowel Diseases
Enrollment 200 participants
Start Date 2020-02-27
Primary Completion 2030-02-27 (estimated)
Study Completion 2033-02-27 (estimated)
Updated on ClinicalTrials.gov 2025-09-18